Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race

被引：0
作者：
Alexis, A. F. [1 ]
Silverberg, J. I. [2 ]
Rice, Z. P. [3 ]
Armstrong, A. W. [4 ]
Desai, S. R. [5 ,6 ]
Fonacier, L. [7 ]
Kabashima, K. [8 ]
Levenberg, M. [9 ]
Biswas, P. [9 ]
Cella, R. Rojo [10 ]
Chan, G. L. [10 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[3] Dermatol Associates Georgia, Atlanta, GA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[5] Innovat Dermatol, Plano, TX USA
[6] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[7] NYU Langone Hosp Long Isl, Mineola, NY USA
[8] Kyoto Univ, Kyoto, Japan
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
516
引用
收藏
页码：E137 / E138
页数：2
相关论文
共 50 条
[31]   Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults [J].
Zhang, Jianzhong ;
Zhao, Yan ;
Zhou, Qinghong ;
Xu, Yuyu .
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 :I54-I55
[32]   Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis [J].
Bernardo, Diana ;
Bieber, Thomas ;
Torres, Tiago .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) :753-764
[33]   SHORT-TERM EFFICACY AND SAFETY OF ABROCITINIB BY BASELINE DISEASE SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS [J].
Rice, Zakiya P. ;
Gooderham, Melinda J. ;
Lebwohl, Mark G. ;
Simpson, Eric L. ;
Boguniewicz, Mark ;
Wollenberg, Andreas ;
Lazariciu, Irina ;
Chan, Gary L. ;
Alderfer, Justine ;
Watkins, Melissa .
ACTA DERMATO-VENEREOLOGICA, 2022, 102 :30-30
[34]   Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis [J].
Wan, Huiying ;
Jia, Haiping ;
Xia, Tian ;
Zhang, Dingding .
DERMATOLOGIC THERAPY, 2022, 35 (09)
[35]   Abrocitinib reduces skin pain in adolescent and adult patients with moderate-to-severe atopic dermatitis [J].
Thyssen, Jacob P. ;
Bewley, Anthony ;
Staender, Sonja ;
Castro, Carla ;
Misery, Laurent ;
Kim, Brian ;
Biswas, Pinaki ;
Chan, Gary ;
Myers, Daniela E. ;
Watkins, Melissa ;
Alderfer, Justine ;
Guler, Erman ;
Silverberg, Jonathan I. .
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) :E118-E118
[36]   Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review [J].
Zhao, Dan-Jie ;
Li, Xia ;
Lin, Hai-Xia ;
Zheng, Hong ;
Zhou, Di ;
Tang, Peng .
PLOS ONE, 2024, 19 (07)
[37]   Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis [J].
Ameen, Mahreen ;
Alhusaye, Raed ;
Brandi, Henrik ;
Bogelund, Mette ;
Jensen, Henrik H. ;
Reitzel, Signe B. ;
Thyssen, Jacob P. .
ACTA DERMATO-VENEREOLOGICA, 2024, 104
[38]   Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J].
Beck, Lisa A. ;
Thaci, Diamant ;
Hamilton, Jennifer D. ;
Graham, Neil M. ;
Bieber, Thomas ;
Rocklin, Ross ;
Ming, Jeffrey E. ;
Ren, Haobo ;
Kao, Richard ;
Simpson, Eric ;
Ardeleanu, Marius ;
Weinstein, Steven P. ;
Pirozzi, Gianluca ;
Guttman-Yassky, Emma ;
Suarez-Farinas, Mayte ;
Hager, Melissa D. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Radin, Allen R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) :130-139
[39]   Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis [J].
Zheng, Hui ;
Chen, Yan ;
Xu, Yunsheng ;
Deng, Xinjie .
EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (05) :530-543
[40]   Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply [J].
Guttman-Yassky, Emma ;
Simpson, Eric L. ;
Reich, Kristian ;
Kabashima, Kenji ;
Igawa, Ken ;
Suzuki, Tetsuya ;
Mano, Hirotaka ;
Matsui, Takeshi ;
Esfandiari, Ehsanollah ;
Furue, Masutaka .
LANCET, 2023, 402 (10415) :1834-1834
12345